161 related articles for article (PubMed ID: 38642318)
1. Discovery of New Dual-Target Agents Against PPAR-γ and α-Glucosidase Enzymes with Molecular Modeling Methods: Molecular Docking, Molecular Dynamic Simulations, and MM/PBSA Analysis.
Kaya S; Tatar-Yılmaz G; Aktar BSK; Emre EEO
Protein J; 2024 Jun; 43(3):577-591. PubMed ID: 38642318
[TBL] [Abstract][Full Text] [Related]
2. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
[TBL] [Abstract][Full Text] [Related]
3. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
Riyaphan J; Pham DC; Leong MK; Weng CF
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
[TBL] [Abstract][Full Text] [Related]
5. Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (
Ahmed S; Ali MC; Ruma RA; Mahmud S; Paul GK; Saleh MA; Alshahrani MM; Obaidullah AJ; Biswas SK; Rahman MM; Rahman MM; Islam MR
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889399
[No Abstract] [Full Text] [Related]
6. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
[TBL] [Abstract][Full Text] [Related]
7.
Osman W; Ismail EMOA; Shantier SW; Mohammed MS; Mothana RA; Muddathir A; Khalid HS
J Recept Signal Transduct Res; 2021 Apr; 41(2):159-169. PubMed ID: 32718219
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics simulations reveal the inhibitory mechanism of Withanolide A against α-glucosidase and α-amylase.
Oyewusi HA; Wu YS; Safi SZ; Wahab RA; Hatta MHM; Batumalaie K
J Biomol Struct Dyn; 2023; 41(13):6203-6218. PubMed ID: 35904027
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory evaluation of
Zabidi NA; Ishak NA; Hamid M; Ashari SE; Mohammad Latif MA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):109-121. PubMed ID: 33249946
[TBL] [Abstract][Full Text] [Related]
10. Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.
Ma Y; Wang SQ; Xu WR; Wang RL; Chou KC
PLoS One; 2012; 7(6):e38546. PubMed ID: 22685582
[TBL] [Abstract][Full Text] [Related]
11. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
Thakral S; Singh V
Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
[TBL] [Abstract][Full Text] [Related]
12. Natural Triterpenoids Isolated from Akebia trifoliata Stem Explants Exert a Hypoglycemic Effect via α-Glucosidase Inhibition and Glucose Uptake Stimulation in Insulin-Resistant HepG2 Cells.
Bian G; Yang J; Elango J; Wu W; Bao B; Bao C
Chem Biodivers; 2021 May; 18(5):e2001030. PubMed ID: 33779055
[TBL] [Abstract][Full Text] [Related]
13. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
Singh G; Singh R; Monga V; Mehan S
Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
15. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
16. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS
Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.
Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM
Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-(phenylsulfonyl)thiazole-2-carboxamides as potent α-glucosidase inhibitors.
Liu J; Li JH; Zhao SY; Chang YQ; Chen QX; Wu WF; Jiao SM; Xiao H; Zhang Q; Zhao JF; Xu J; Sun PH
Drug Dev Res; 2024 Feb; 85(1):e22128. PubMed ID: 37984820
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
Ihmaid S
Molecules; 2018 May; 23(6):. PubMed ID: 29844263
[TBL] [Abstract][Full Text] [Related]
20. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
Zahra S; Zaib S; Khan I
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
